Canada's Health Minister moves on safe prescribing practices for drugs prone to abuse

29 July 2014

Canada’s Minister of Health, Rona Ambrose, has issued a national Call for Proposals to improve the prescribing practices for prescription drugs that have a high risk of abuse or addiction.

The country’s regulator, Health Canada, will devote C$3.6 million ($3.3 million) to support the development of evidence-based practices for appropriate prescribing of the most commonly abused classes of prescription drugs: opioids, stimulants, sedatives and tranquillizers.

The Call for Proposals is aimed at projects that will improve prescribing practices and the educational needs of healthcare practitioners. It also focuses on projects that will develop new approaches, training and tools to improve these prescribing practices. This builds on actions already taken by the government to address the important issue of prescription drug abuse.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK